UK Markets open in 7 hrs 3 mins

Allergy Therapeutics plc (AGY.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
19.00-0.50 (-2.56%)
At close: 04:34PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.57
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 340.50
52-week low 318.00
50-day moving average 321.82
200-day moving average 328.03

Share statistics

Avg vol (3-month) 339.83k
Avg vol (10-day) 331.64k
Shares outstanding 5641.8M
Implied shares outstanding 6N/A
Float 8349.86M
% held by insiders 1100.80%
% held by institutions 16.71%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Jun 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin -6.81%
Operating margin (ttm)-5.62%

Management effectiveness

Return on assets (ttm)-2.90%
Return on equity (ttm)-9.47%

Income statement

Revenue (ttm)79M
Revenue per share (ttm)0.12
Quarterly revenue growth (yoy)-9.90%
Gross profit (ttm)62.23M
EBITDA -1.88M
Net income avi to common (ttm)-5.38M
Diluted EPS (ttm)0.40
Quarterly earnings growth (yoy)-55.30%

Balance sheet

Total cash (mrq)41.38M
Total cash per share (mrq)0.06
Total debt (mrq)9.93M
Total debt/equity (mrq)18.06
Current ratio (mrq)3.80
Book value per share (mrq)0.08

Cash flow statement

Operating cash flow (ttm)-1.03M
Levered free cash flow (ttm)-690k